News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria
Thursday, October 24, 2024Jasper Therapeutics Inc a clinical stage biotechnology company focused on development of briquilimab a novel antibody therapy targeting cKit CD to address mast cell driven diseases such as chronic spontaneous urticaria CSU chronic inducible urticaria...
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Wednesday, October 23, 2024Virax Biolabs Group Limited an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases today announced that it has entered into a distribution agreement with Europa Biosite to commercialize the co...
BioVersys Joins EU-Funded RespiriNTM Programme to Accelerate Development of Its Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases
Tuesday, October 22, 2024BioVersys AG a multiasset clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious lifethreatening infections caused by multidrug resistant MDR bacteria announced today that it has join...
Virscio Extends Translational Expertise and Research Services to Molecular Biology
Tuesday, October 22, 2024Virscio a leading translational research organization today announced the launch of its new molecular biology division The addition of advanced molecular research capabilities to Virscios services portfolio enables highthroughput tissue sample proces...
Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series
Monday, October 21, 2024Agilent Technologies Inc today announced the release of its next generation Agilent InfinityLab LC Series portfolio which includes the Infinity III LC Infinity III Prime LC and Infinity III LC systems all including the biocompatible versions These...
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)
Friday, October 18, 2024ARTHEx Biotech SL a clinicalstage biotechnology company focused on developing innovative medicines through the modulation of gene expression announced today that the first participant has been dosed in the Randomized Placebo Controlled Double Blind P...
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development
Friday, October 18, 2024Nusano a physics company transforming the production of radioisotopes and Starget Pharma a clinicalstage biotechnology company developing precision peptide radioligand therapies focused on difficult to treat cancers today announced a supply agreement...
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
Thursday, October 17, 2024Valneva SE a specialty vaccine company and LimmaTech Biologics AG a clinicalstage biotech company developing vaccines for the prevention of lifethreatening diseases announced today that the US Food and Drug Administration FDA has granted Fast Track d...
Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
Thursday, October 17, 2024Cellular Origins and Fresenius Kabi an operating company of Fresenius announce today they have signed a development agreement that leverages each companys expertise in cell and gene therapies CGTsThe agreement is designed with the goal of digitally a...
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
Wednesday, October 16, 2024Cytosurge AG a leader in singlecell manipulation and Lexogen a pioneer in RNA sequencing solutions have announced their partnership to advance livecell sequencing Liveseq The collaboration integrates Cytosurges FluidFM OMNIUM platform with Lexogens L...
